Cleveland Clinic International IV Robotics Summit.

compounding intravenous medications medication safety robotic technology robots

Journal

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
ISSN: 1535-2900
Titre abrégé: Am J Health Syst Pharm
Pays: England
ID NLM: 9503023

Informations de publication

Date de publication:
22 04 2021
Historique:
pubmed: 19 2 2021
medline: 30 9 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

The proceedings of an international summit on the current and desired future state of use of robotic systems to compound intravenous (IV) solutions are summarized. The International IV Robotics Summit was held at the Cleveland Clinic main campus in Cleveland, OH, on April 29 and 30, 2019. The purpose of the summit was 2-fold: (1) to define the current state of robotic IV compounding and (2) to develop a guide for automation companies, pharmacy departments, and drug manufacturers to improve the technology and expand the use of IV robotics in health systems in the future. The first day of the summit included 45-minute presentations by each of the speakers. Each lecturer recounted a different hospital's experience implementing and using IV robotics. On day 2 of the summit, an expert panel dedicated to mapping the future of IV robotics was convened to determine barriers to widespread adoption of IV robotics in health systems and offer potential solutions to remove these barriers. The expert panel targeted 3 specific audiences: robot manufacturers, drug manufacturers, and fellow pharmacy leaders. It is the hope of the international faculty that the information that emerged from the summit can be used by others to successfully implement IV compounding robotics in their sterile products areas to maximize patient safety. The summit also served as a call to action for pharmacy leaders, drug manufacturers, and robotic companies to develop a safer, more efficient future for patients by working together to optimize the development and operation of IV robotics.

Identifiants

pubmed: 33599751
pii: 6144027
doi: 10.1093/ajhp/zxab050
pmc: PMC7929424
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

800-805

Informations de copyright

© American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jordan Long (J)

Cleveland Clinic, Cleveland, OH, USA.

Samuel Calabrese (S)

Cleveland Clinic, Cleveland, OH, USA.

Ahmed Al-Jedai (A)

Ministry of Health, Riyadh, Saudi Arabia.

Anthony Boyd (A)

Cleveland Clinic, Cleveland, OH, USA.

Michael Cotugno (M)

Brigham and Women's Hospital, Boston, MA, USA.

Mitchell Dorn (M)

Ohio State University Wexner Medical Center, Columbus, OH, USA.

John Fanikos (J)

Brigham and Women's Hospital, Boston, MA, USA.

Michael J Freudiger (MJ)

Valley Children's Healthcare, Madera, CA, USA.

Irene Kraemer (I)

University Medical Center, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Carmen Lopez-Cabezas (C)

Hospital Clinic of Barcelona, Barcelona, Spain.

Abbi Smith (A)

Cleveland Clinic, Cleveland, OH, USA.

Francine M de Stoppelaar (FM)

Cleveland Clinic London, London, United Kingdom.

Jerry Usher (J)

Duke University Hospital, Durham, NC, USA.

Angela W Yaniv (AW)

Cleveland Clinic, Cleveland, OH, USA.

Scott Knoer (S)

American Pharmacists Association, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH